https://www.taxtmi.com/news?id=60367 Accubits Invent secured a patent for the VolTrac VOC sensor in 2024, claiming parts-per-trillion sensitivity and 98.5% lab-verified accuracy for disease-specific VOC signatures within 90 seconds; the patent underpins planned commercialization. The company is preparing for clinical trials and regulatory certification as prerequisites to market entry, intending deployment for point-of-care screening, continuous monitoring, telemedicine, and public-health surveillance. A companion product, DeTecX, targets rapid airborne pathogen detection and real-time alerts, and both products are positioned to generate VOC datasets for epidemiological and AI-driven predictive applications. en-us Sat, 01 Nov 2025 15:31:03 +0530 Sat, 01 Nov 2025 15:31:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=60367 Accubits Invent secured a patent for the VolTrac VOC sensor in 2024, claiming parts-per-trillion sensitivity and 98.5% lab-verified accuracy for disease-specific VOC signatures within 90 seconds; the patent underpins planned commercialization. The company is preparing for clinical trials and regulatory certification as prerequisites to market entry, intending deployment for point-of-care screening, continuous monitoring, telemedicine, and public-health surveillance. A companion product, DeTecX, targets rapid airborne pathogen detection and real-time alerts, and both products are positioned to generate VOC datasets for epidemiological and AI-driven predictive applications. News - Sat, 01 Nov 2025 15:31:03 +0530 https://www.taxtmi.com/news?id=60367